At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
In Brief
A Phase 3 clinical trial evaluating Radiation Therapy, Questionnaire Administration, and 3 other interventions for Ductal Breast Carcinoma and 8 related conditions. Active but no longer recruiting, targeting 898 participants across 859 sites in 2 countries.
Detailed Summary
This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery and have fewer side effects.
Study Details
Timeline
Interventions
Undergo RT
Ancillary studies
Ancillary studies
Correlative studies
Undergo hypofractionated RT